« Possible Heart Risk With Testosterone Spurs Debate on Use | Main | FDA says asthma drug Xolair raises risk of heart, brain problems »

September 18, 2014

FDA panel backs limiting use of testosterone replacement drugs

Quoted from http://www.reuters.com/article/2014/09/17/usa-health-testosterone-idUSL1N0RI2V820140917

FDA panel backs limiting use of testosterone replacement drugs

Wed Sep 17, 2014

By Toni Clarke

Sept 17 (Reuters) - Testosterone replacement therapies should be reserved for men with specific medical conditions that impair function of the testicles, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.

The FDA is not obliged to follow the advice of its advisory panels but typically does so. The panel also recommended that companies be required to conduct additional studies to assess the cardiovascular risk of their products for patients with age-related low testosterone.

Prescriptions for "Low T," as low testosterone has been described in television commercials, have soared over the past decade, driven by an increase in use by middle-aged men with lowered testosterone levels related to advancing age.

[Article continues at original source]

Related articles
The Benefits And Risks Of Popular Testosterone Replacement Therapy For Older Men Are Not Fully Known
Testosterone Drugs FDA Meeting In September 2014 Reveals That The Safety Of Products Like Axiron, AndroGel, And Testim Is Uncertain Or Unknown At Present Time

Posted at 03:01 PM in AndroGel, Axiron, Testim, Testosterone Therapy |

Tags: Androderm, AndroGel, Axiron, Bio-T-Gel, cardiovasucular safety, CVA, Delatestryl, Depo-Testosterone, drug injury, FDA study, Fortesta, heart attacks, increased risks, Low-T drugs , MI, myocardial infarctions, side effects, Striant, strokes, Testim, Testopel, testosterone products

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required